EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms-Reference-Cited by-同舟云学术

EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms

Published:2015-07 Issue:3 Volume:81 Page:410-413
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Mintziori Gesthimani,Lambrinoudaki Irene,Goulis Dimitrios G.,Ceausu Iuliana,Depypere Herman,Erel C. Tamer,Pérez-López Faustino R.,Schenck-Gustafsson Karin,Simoncini Tommaso,Tremollieres Florence,Rees Margaret

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference51 articles.

1. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging;Harlow;Climacteric,2012

2. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages;Deecher;Arch Women's Mental Health,2007

3. Estrogens, hormone therapy, and hippocampal volume in postmenopausal women;Wnuk;Maturitas,2012

4. Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era;Rossouw;Maturitas,2010

5. Concomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness;Gardiner;Maturitas,2011

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE study;Maturitas;2024-11

2. Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe;Maturitas;2024-10

3. Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial;Climacteric;2024-09-10

4. Effectiveness of Commercial Red Clover (Trifolium pratense L.) Products for the Treatment of Symptoms in Menopausal Women—A Narrative Review;Nutraceuticals;2024-09-09

5. Prevalence and impact of vasomotor symptoms associated with menopause among women in Brazil: Subgroup analysis from an international cross-sectional survey;Maturitas;2024-09